Cerity Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
SCM
Cerity Partners's HALO Position: Q2 2026 in Review
Cerity Partners reduced its Halozyme (HALO) stake by 1.6% in Q2 2026, selling an estimated $378K and leaving 343,589 shares worth $26.9M. The position accounts for 0.03% of the portfolio, ranked #397.
Cerity Partners first reported a position in HALO in Q2 2022 and has held it in 17 quarters since. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Cerity Partners held 343,589 shares of Halozyme worth $26.9M as of Q2 2026.
- Cerity Partners sold 5,548 Halozyme shares in Q2 2026, an estimated $378K.
- Halozyme made up 0.03% of Cerity Partners's portfolio in Q2 2026, its #397 holding.
- Cerity Partners first reported a position in Halozyme in Q2 2022 and has held it in 17 quarters since.
- 629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.